High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study.

Getnet Yimer,Wondwossen Amogne,Abiy Habtewold,Eyasu Makonnen,Nobuhisa Ueda,A. Suda,Alemayehu Worku,Walter E. Haefeli,Juergen Burhenne,Getachew Aderaye,Lars Lindquist,Eleni Aklillu

High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study.

2012

Getnet Yimer
Wondwossen Amogne
Abiy Habtewold
Eyasu Makonnen
Nobuhisa Ueda
A. Suda
Alemayehu Worku
Walter E. Haefeli
Juergen Burhenne
Getachew Aderaye
Lars Lindquist
Eleni Aklillu

High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naive HIV patients from Ethiopia: a prospective cohort study

Keywords:

Prospective cohort study
Efavirenz
Immunology
Liver injury
Biology
Biomarker (medicine)
Survival analysis
Pharmacology
Gastroenterology
Pharmacogenetics
Viral load
Internal medicine
Proportional hazards model

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations